跳至主要内容
临床试验/NCT04526301
NCT04526301Unknown不适用

Home With TablO outcoMEs (HOME) Registry

Outset Medical10 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2020年7月14日最近更新:
适应症

试验速览

阶段
不适用
入组人数
500
试验地点
10
主要终点
Weekly Standardized Dialysis Adequacy

研究概览

简要总结

Prospective, multicenter, single arm, post-market study to evaluate real world clinical outcomes in ESRD patients receiving in-home dialysis on the Tablo Hemodialysis System.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
15 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participant (patient and/or care partner) is at least 15 years of age and has provided informed consent and has signed a Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant authorization statement.
  • Participant weighs ≥ 34kg.
  • Participant has end stage renal disease (ESRD) adequately treated by maintenance dialysis.
  • Participant plans to start or has started home treatment (≤ 6 months) with the Tablo Hemodialysis System.
  • Participant is willing and able to comply with the Protocol requirements and perform all site required treatments and clinical evaluations.

排除标准

  • Participant and/or care partner is unable to read English or Spanish.
  • Participant has a home environment that is deemed inappropriate for home dialysis.
  • Participant and/or care partner is unable to successfully complete the Tablo training program
  • Participant is pregnant or plans to become pregnant.

结局指标

主要结局

Weekly Standardized Dialysis Adequacy

时间窗: 12-months

Weekly standardized dialysis adequacy (stdKt/V) measured using the second-generation formula of Daugirdas. This formula normalizes urea clearance among heterogeneous hemodialysis schedules, where K=dialyzer clearance or urea, t=treatment time, and V=subject's volume of urea distribution. stdKt/V values of ≥ 2.1 are regarded as being adequate.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验